Fact CheckerSign in

NCT05944302Completed

EMDR on Pain in Patients With in Patients Rheumatoid Arthritis

Effect of Eye Movement Desensitization and Reprocessing (EMDR) on Pain in Patients With in Patients Rheumatoid Arthritis

Source: ClinicalTrials.gov · Last updated 19 Jul 2024

Brief summary (registry, in English)

They explained the improvement of pain in patients with EMDR treatment in chronic pain with Shapiro's adaptive information processing model. According to this model; The nociceptive sense is related to the emotional response. During the traumatic event, the painful stimulus is stored both physically and as an image, thought, and affect. Therefore, traumatic memories contain affective elements as well as conscious awareness and contribute significantly to stress along with chronic pain. Reprocessing these dysfunctionally stored memories will allow the problematic memories to integrate, resulting in both symptom relief and increased personal efficacy. According to the explanations made with the adaptive information processing model, the perception of the traumatic event is reprocessed with bidirectional stimulation given its somatic and affective components, and the cortical integration of the memory is provided. Changing the emotional dimension of pain may lead to changes in pain pathways, altering the memory and reproduction of pain in the nervous system. When desensitization is achieved against negative emotions; It has been hypothesized that once the patient has a more normal response to pain or stress, it will not revert to a limbic magnified response of pain unless a new trauma has been experienced. Painful conditions can continue to bother even after the illness or injury has been successfully treated. This may be the result of improperly stored memories and chronic active pain. In addition to medication, physical therapy, patient education and psychological support are very important in relieving rheumatological pain.

Status (registry)
Completed
Study type
Interventional
Enrollment
64 (actual)
First submitted
9 Jun 2023
Start date
13 Jul 2023
Primary completion date
2 Jul 2024
Lead sponsor
Mersin University
NCT number
NCT05944302

What you commit to

  • Study type: Interventional
  • Participants enrolled: 64
  • From 13 Jul 2023 to the primary completion date, 2 Jul 2024
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Who cannot complete the EMDR application for any reason (health problem, not being able to spare time)
  • Patients who want to leave the study voluntarily will be excluded from the follow-up.

Who the study is looking for

  • Under 18 years of age,
  • Receiving another psychosocial therapy on working dates,
  • Those who do not agree to participate in the research,
  • Pregnancy,
  • VAS pain score less than 4,
  • Using analgesic medication at least 4 hours ago,
  • Having a physical/mental disability or disability and illness that would prevent them from participating in EMDR,

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mersin University
Coordinator of this site? Confirm its status
MersinTurkey (Türkiye)Unknown status
Mersin University Hospital
Coordinator of this site? Confirm its status
MersinTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.